Digital Journal

Antimicrobial Susceptibility Testing (AST) Market Size to Surpass USD 5.35 billion by 2031, exhibiting a CAGR of 5.2%

0


The global Antimicrobial Susceptibility Testing (AST) market is experiencing an increase in demand, driven by the critical need to combat the rising threat of antimicrobial resistance (AMR).

According to SNS Insider, the Antimicrobial Susceptibility Testing (AST) market size is expected to reach USD 5.35 Billion by 2031 and grow at a CAGR of 5.2% over the forecast period of 2024-2031.

Antimicrobial Susceptibility Testing Market
Antimicrobial Susceptibility Testing Market

Antimicrobial Susceptibility Testing (AST) plays an important role in guiding effective antibiotic treatment for infectious diseases by determining which specific antibiotics a particular microorganism is susceptible to. This targeted approach not only improves patient outcomes but also helps curb the development and spread of antibiotic-resistant bacteria.

Download Free Sample Report of Antimicrobial Susceptibility Testing Market @ https://www.snsinsider.com/sample-request/1897

List of Antimicrobial Susceptibility Testing Companies Profiled in Report:

  • Bio-Rad
  • BD
  • Danaher
  • Thermo Fisher Scientific
  • Accelerate Diagnostics
  • Merck Group
  • Creative Diagnostics
  • Alifax
  • Roche Diagnostics Limited
  • Synbiosis

Key Characteristics of Product Portfolios.

Kits and Reagents: These form the backbone of Antimicrobial Susceptibility Testing (AST), providing standardized and rapid methods for testing susceptibility.

Instruments: Automated systems and advanced technologies like MALDI-TOF (Matrix-assisted laser desorption/ionization-time of flight) are increasingly sought after for their speed, accuracy, and efficiency.

Consumables: Petri dishes, media plates, and other disposable items used throughout the testing process.

What are the factors on which companies should focus to improve their overall market development?

  • Rising Prevalence of Hospital-Acquired Infections (HAIs): The growing number of HAIs, often caused by multidrug-resistant (MDR) pathogens, necessitates the use of AST for optimal treatment selection.
  • Increased Awareness of AMR: Public health initiatives and growing awareness of AMR are driving the adoption of AST to promote responsible antibiotic use.
  • Technological Advancements: Continuous innovation in AST methods, including rapid diagnostics and automation, is streamlining workflows and improving test accuracy.
  • Focus on Personalized Medicine: Tailoring treatment based on individual patient needs, including susceptibility profiles, is gaining traction, further propelling the AST market.

Antimicrobial Susceptibility Testing Industry Segmentation as Follows:

By Product

  • Manual Tests
  • MIC Strips
  • Susceptibility Testing Disks
  • Susceptibility Plates
  • Automated Instruments
  • Consumables & Media

By Technique

  • Automated AST
  • Etest Method
  • Dilution
  • Disk Diffusion
  • Others

By Application

  • Drug Development
  • Susceptibility Testing
  • Others

By End-Use

  • Hospitals
  • Diagnostic Laboratories
  • Biotechnology & Pharmaceutical Companies
  • Others

Ask Your Query Before Buying this Research Report @ https://www.snsinsider.com/enquiry/1897

Segment Analysis:

In depth study of antimicrobial landscape requires a multi-divided approach. Segmenting AST by technique offers a granular view of market dynamics. Automated AST systems, employing robotics and advanced algorithms, streamline testing and enhance workflow efficiency. This segment provides to high-volume laboratories seeking rapid results. Conversely, the Etest method provides a user-friendly alternative for susceptibility gradient determination, particularly valuable in research settings or smaller labs. Traditional techniques like dilution and disk diffusion, while potentially more labour-intensive, retain their importance due to cost-effectiveness and established protocols. Beyond these core methods, the market encompasses a range of specialized techniques, each addressing specific needs.

Regional Landscape:

The AST market exhibits a dynamic regional landscape with distinct growth patterns. North America currently holds a dominant position due to well-established healthcare infrastructure, high adoption rates of advanced technologies, and robust government support for AMR research. Europe is another significant market, driven by stringent regulations on antibiotic use and growing investments in diagnostic tools. However, healthcare budget constraints in some European countries might limit market expansion. The Asia Pacific region presents a promising future market with a rising burden of infectious diseases and increasing healthcare spending. China and India, in particular, are expected to witness exponential growth due to their large patient populations and growing focus on improving healthcare access.

Recent Developments:

  • Becton Dickinson (BD) offers a comprehensive portfolio of AST products, including automated systems and rapid diagnostic tests.
  • bioMérieux provides a wide range of AST solutions, including VITEK® 2, a widely used automated system.
  • Siemens Health focuses on advanced technologies like MALDI-TOF mass spectrometry for rapid microbial identification and AST.
  • Abbott Diagnostics is known for its innovative diagnostic tests like the MicroScan WalkAway system for automated AST.

Key Takeaways:

  • Improve patient outcomes by ensuring effective treatment from the outset.
  • Reduce healthcare costs associated with prolonged hospital stays and treatment failures.
  • Minimize the emergence and spread of antibiotic-resistant pathogens.
  • Promote responsible antibiotic stewardship, preserving the efficacy of these life-saving drugs.
  • As the global healthcare community strives to combat the growing threat of AMR, the AST market is poised for continued growth. By harnessing the power of innovation and collaboration, stakeholders can leverage this market to ensure a future where effective antibiotics remain a cornerstone of patient care.

Buy Antimicrobial Susceptibility Testing Market report @ https://www.snsinsider.com/checkout/1897

Table of Content

Chapter 1 Introduction

Chapter 2 Research Methodology

Chapter 3 Antimicrobial Susceptibility Testing Market Dynamics

Chapter 4 Impact Analysis (COVID-19, Ukraine- Russia war, Ongoing Recession on Major Economies)

Chapter 5 Value Chain Analysis

Chapter 6 Porter’s 5 forces model

Chapter 7 PEST Analysis

Chapter 8 Antimicrobial Susceptibility Testing Market Segmentation, By Product

Chapter 9 Antimicrobial Susceptibility Testing Market Segmentation, By Technique

Chapter 10 Antimicrobial Susceptibility Testing Market Segmentation, By Application

Chapter 11 Antimicrobial Susceptibility Testing Market Segmentation, By End-Use

Chapter 12 Regional Analysis

Chapter 13 Company profile

Chapter 14 Competitive Landscape

Chapter 15 Use Case and Best Practices

Chapter 16 Conclusion

Continued…

For more information and a comprehensive analysis of the market, please refer to the full report available at https://www.snsinsider.com/reports/antimicrobial-susceptibility-testing-market-1897

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com/



Information contained on this page is provided by an independent third-party content provider. Binary News Network and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]

ED

Retail Point-of-Sale Terminals Market to Cross USD 55.6 Billion by 2031 Driven by Mobile POS Adoption and Wireless Technology

Previous article

Industrial Metrology Market to Hit USD 23.4 Billion by 2031 Driven by Rising Demand for Quality and Automation

Next article

You may also like

Comments

Comments are closed.